Results 131 to 140 of about 8,067 (198)

Nociceptor deletion of Tsc2 enhances axon regeneration by inducing a conditioning injury response in dorsal root ganglia [PDF]

, 2019
Carlin, Dan, Cavalli, Valeria, Ewan, Eric E, Halevi, Alexandra E, Moore, Amy M   +4 more
core   +1 more source

RET signaling is required for survival and normal function of nonpeptidergic nociceptors [PDF]

, 2010
Enomoto, Hideki, Gereau, Robert W, IV, Golden, Judith P, Hoshi, Masato, Jain, Sanjay, Johnson, Eugene M, Jr, Milbrandt, Jeffrey, Nassar, Mohammed A, Wood, John N   +8 more
core   +2 more sources

Is Nav1.8-specific inhibition the only path? Preferential Nav blockers offer a compelling alternative. [PDF]

Proc Natl Acad Sci U S A
Xiang B, Deng C, Yang H, Zhang W.
europepmc   +1 more source

A paradigm shift in analgesic discovery: from rodent to human models. [PDF]

Korean J Pain
Han RT.
europepmc   +1 more source

Beyond Opioids: A Review of Suzetrigine for Acute Pain Management. [PDF]

Int J Mol Sci
Pham A, Yep H, Wozniak S, Javvaji A, Nada E, Bergese S.   +5 more
europepmc   +1 more source

Suzetrigine and the evolving landscape of non-opioid analgesia. [PDF]

Br J Pain
Cheema ZZ, Hassan E, Siddiq N.
europepmc   +1 more source

Una mutación con cambio de sentido c.1661T>C en el gen SCN10A que genera ganancia de función del canal Nav1.8 y síndrome de QT largo congénito

Revista Interamericana de Cardiología
Introducción: Las mutaciones con ganancia de función del canal Nav1.8, codificado por el gen SCN10A, se asocian a neuropatía periférica dolorosa. Evidencias recientes indican que las mutaciones de SCN10A pueden asociarse a canalopatías cardíacas como el ...
Hyun S. Yoo, Pablo A. Fernández, Daniel E. Etcheverry, Hugo A. Garro, Florencia Muschietti, Paola Settepassi, Rocío Villa-Fernández, Analia G. Paolucci, Mario B. Principato, Justo Carbajales   +9 more
doaj  

Contusive spinal cord injury causes Nav1.8 dysfunction to upregulate small sensory neuron excitability. [PDF]

J Physiol
Xiao Y, Pan Y, Liu N, Cummins TR.
europepmc   +1 more source

Centrally Acting Skeletal Muscle Relaxants Sharing Molecular Targets with Drugs for Neuropathic Pain Management. [PDF]

Brain Sci
Kirchlechner-Farkas JM, Karadi DA, Boldizsár I, Essmat N, Galambos AR, Lincmajer ZP, Abbood SK, Király K, Szökő É, Tábi T, Al-Khrasani M.   +10 more
europepmc   +1 more source

Suzetrigine for the Treatment of Acute Pain: Reply. [PDF]

Anesthesiology
Bertoch T, Bozic C, Weiner SG.
europepmc   +1 more source